NCT01991366View on ClinicalTrials.gov

Should Integrilin be an Integral Part of Adjunctive Therapy in Patients Undergoing Primary PCI for ST-Elevation MI?

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

October 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

June 30, 2021

Conditions
ST-elevation Myocardial InfarctionAcute Myocardial Infarction
Trial Locations (1)

20010

Washington Hospital Center, Washington D.C.

Sponsors
All Listed Sponsors
lead

Medstar Health Research Institute

OTHER

NCT01991366 - Should Integrilin be an Integral Part of Adjunctive Therapy in Patients Undergoing Primary PCI for ST-Elevation MI? | Biotech Hunter | Biotech Hunter